BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37819165)

  • 1. Localized Imaging of Programmed Death-Ligand 1 on Individual Tumor-Derived Extracellular Vesicles for Prediction of Immunotherapy Response.
    Zhang J; Guan M; Lv M; Liu Y; Zhang H; Zhang Z; Zhang K
    ACS Nano; 2023 Oct; 17(20):20120-20134. PubMed ID: 37819165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
    Serratì S; Guida M; Di Fonte R; De Summa S; Strippoli S; Iacobazzi RM; Quarta A; De Risi I; Guida G; Paradiso A; Porcelli L; Azzariti A
    Mol Cancer; 2022 Jan; 21(1):20. PubMed ID: 35042524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
    Dou X; Hua Y; Chen Z; Chao F; Li M
    Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles.
    Khan A; Di K; Khan H; He N; Li Z
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
    Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
    Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Recognition-Mediated Autocatalytic Amplification Assay for the Subpopulations of PD-L1 Positive Extracellular Vesicle.
    Ren Y; Ge K; Tang Q; Liang X; Fan L; Ye K; Wang M; Yao B
    Anal Chem; 2024 Jun; 96(23):9585-9592. PubMed ID: 38816678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model.
    Veerman RE; Akpinar GG; Offens A; Steiner L; Larssen P; Lundqvist A; Karlsson MCI; Gabrielsson S
    Cancer Immunol Res; 2023 Feb; 11(2):217-227. PubMed ID: 36546872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.
    Schöne N; Kemper M; Menck K; Evers G; Krekeler C; Schulze AB; Lenz G; Wardelmann E; Binder C; Bleckmann A
    J Extracell Vesicles; 2024 Mar; 13(3):e12418. PubMed ID: 38453684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle-mediated immunoregulation in cancer.
    Yamamoto T; Yamamoto Y; Ochiya T
    Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
    Liang Y; Liu Y; Zhang Q; Zhang H; Du J
    Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC.
    Shukuya T; Ghai V; Amann JM; Okimoto T; Shilo K; Kim TK; Wang K; Carbone DP
    J Thorac Oncol; 2020 Nov; 15(11):1773-1781. PubMed ID: 32565389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
    Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
    J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
    Yoh KE; Lowe CJ; Mahajan S; Suttmann R; Nguy T; Reichelt M; Yang J; Melendez R; Li Y; Molinero L; Ruppel J; Xu W; Plaks V
    J Immunol Methods; 2021 Mar; 490():112936. PubMed ID: 33242493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
    Lee CH; Bae JH; Choe EJ; Park JM; Park SS; Cho HJ; Song BJ; Baek MC
    Theranostics; 2022; 12(5):1971-1987. PubMed ID: 35265193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Detection of PD-L1 Protein and mRNA in Tumor Cells and Extracellular Vesicles through a Real-Time qPCR Assay.
    Peng W; Sun D; Lu W; Yin S; Ye B; Wang X; Ren Y; Hong Z; Zhu W; Yu P; Xi JJ; Yao B
    Anal Chem; 2023 Jul; 95(28):10625-10633. PubMed ID: 37424077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response.
    Zhang Y; Zhang K; Wen H; Ge D; Gu J; Zhang C
    Clin Exp Immunol; 2024 Mar; 216(1):68-79. PubMed ID: 38146642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment.
    Zhou Y; Yamamoto Y; Takeshita F; Yamamoto T; Xiao Z; Ochiya T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1-Expressing Extracellular Vesicles for the Treatment of Pneumonia.
    Wu Y; Wang H; Song A; Wang X; Ma Q; Yao C; Xu J; Dai H; Wang C; Lu T; Xu F
    ACS Biomater Sci Eng; 2023 Nov; 9(11):6464-6471. PubMed ID: 37844209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.